EGFR and non-small cell lung carcinoma: In this context, thanking the central nervous system penetration of osimertinib, CT scans (supplemented by brain magnetic resonance imaging in case of doubtful findings) can be particularly useful in detecting brain metastases, a common site of recurrence in EGFR-mutant NSCLC.